For the Inventor, By the Inventor

Enter assignee name

Durham, NC, United States of America

Affinergy Inc.

USPTO Granted Patents = 19

% Expired Patents = 84.2

EPO Patents = 2

Forward Citations = 52

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Paul Theodore Hamilton (17 out of 34 patents)

Wayne F Beyer (7 out of 34 patents)

Ray Edward Benson (7 out of 11 patents)

4. Robin Hyde-DeRuyscher (7 out of 11 patents)

5. Shrikumar Ambujakshan Nair (6 out of 6 patents)

6. Martyn Kerry Darby (4 out of 4 patents)

7. Hanne Gron (4 out of 6 patents)

8. Yuchen Chen (3 out of 7 patents)

9. Isaac Gilliam Sanford (3 out of 3 patents)

10. R Edward Benson (3 out of 3 patents)

11. Daniel James Kenan (3 out of 3 patents)

12. Elliott A Gruskin (2 out of 41 patents)

13. Doug Buechter (2 out of 4 patents)

14. John P O'Brien (2 out of 50 patents)

15. Stephen R Fahnestock (2 out of 26 patents)

19 patents: Sort by Forward Citations

1. 9279810 - Cell binding peptides for diagnosis and detection (2016-03-08),

2. 8779089 - Methods and compositions for soft tissue repair (2014-07-15),

3. 8691946 - Methods and compositions for soft tissue repair (2014-04-08),

4. 8637455 - Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces (2014-01-28),

5. 8273337 - Hair binding peptides and peptide-based hair reagents for personal care (2012-09-25),

6. 8263056 - Dyed-hair-binding peptides and peptide-based hair reagents for personal care (2012-09-11),

7. 8067021 - Methods and compositions for delivery of growth factor to fibrous connective tissue (2011-11-29),

8. 7994277 - IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants (2011-08-09),

9. 7977313 - Methods and compositions for promoting localization of pharmaceutically active agents to bone (2011-07-12),

10. 7972615 - Peptide compositions for coating metal medical devices with vancomycin (2011-07-05),

11. 7968677 - IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants (2011-06-28),

12. 7812119 - IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants (2010-10-12),

13. 7807624 - Methods and compositions for promoting attachment of cells of endothelial cell lineage to medical devices (2010-10-05),

14. 7795383 - IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants (2010-09-14),

15. 7790844 - IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants (2010-09-07),

Company Overview

Affinergy Inc. is a biotechnology company based in Durham, NC, specializing in the development of innovative biomaterials and surface modification technologies. The company focuses on creating solutions that enhance the performance of medical devices and therapeutic applications. By leveraging its expertise in protein engineering and polymer chemistry, Affinergy aims to improve patient outcomes through advanced materials that promote biocompatibility and functionality in various healthcare settings.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

19 Patents

#44 in

#17,150 in

#32,693 in the World

Durham, NC, United States of America

Affinergy Inc.

Forward Citations = 52

33 inventors:

Paul Theodore Hamilton (17 out of 34 patents)

Wayne F Beyer (7 out of 34 patents)

Ray Edward Benson (7 out of 11 patents)

4. Robin Hyde-DeRuyscher (7 out of 11 patents)

5. Shrikumar Ambujakshan Nair (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Affinergy Inc.. Retrieved from https://idiyas.com/company/affinergy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…